Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04974398
Title A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Akeso
Age Groups: child | adult | senior
Covered Countries USA | CAN | AUS

No variant requirements are available.